Results 181 to 190 of about 152,178 (350)
International Journal of Cancer, Volume 158, Issue 5, Page 1184-1192, 1 March 2026.What's New? The prognostic significance of the presence or absence of human epidermal growth factor receptor 2 (HER2) and estrogen receptor (ER) in breast cancer is well‐established. However, the relationship of HER2 and ER with distant disease recurrence and metastasis location is less well understood.
Damien Kaukonen +4 more
wiley +1 more source
Journal of Applied Toxicology, Volume 46, Issue 3, Page 733-753, March 2026.ABSTRACT The widespread use of antineoplastic drugs in cancer treatment has led to significant concerns regarding the potential health risks posed to healthcare professionals involved in the preparation, administration, and handling of these chemical compounds, including genotoxicity.
Thiago Guedes Pinto +6 more
wiley +1 more source
India's Health Diplomacy: Advancing Pharmaceutical and MedTech Leadership in the Global South
World Medical &Health Policy, Volume 18, Issue 1, March 2026.ABSTRACT Health diplomacy has become a pivotal aspect of India's engagement with the Global South, intertwining foreign policy, public health, and global collaboration to address disparities while pursuing strategic interests. India's pharmaceutical industry, which accounts for nearly 20% of the world's generics, has positioned the nation as the ...
Gaurav Chanderprakash Mittal +4 more
wiley +1 more source
Prescription for the People: An Activist\u27s Guide to Making Medicine Affordable for All [PDF]
, 2017 [Excerpt] Because every cure starts with an accurate diagnosis, in this book I explain how and why the current medicines system is dysfunctional and corrupt.
Quigley, Fran
core +1 more source
International Journal of Cancer, Volume 158, Issue 4, Page 1106-1115, 15 February 2026.What's new? Progesterone receptor (PR) expression in breast cancer is influenced by menopausal status and PR positivity is more common in premenopausal women. The influence of PR intra‐tumor heterogeneity on distant recurrence risk in premenopausal women, however, remains unknown. In this investigation, variations in PR expression within breast tumors,
Oscar Danielsson +13 more
wiley +1 more source
Long-term responders to trastuzumab monotherapy in the first-line metastatic setting: characteristics and survival data (SAKK 22/99 Trial) [PDF]
, 2017 Sabine Schmid +15 more
openalex +1 more source
Advanced Science, Volume 13, Issue 7, 3 February 2026.In vivo optical imaging enhances antibody‐drug conjugate (ADC) optimization by enabling real‐time monitoring of stimulus‐responsive drug behavior. We report n501‐CYMMAF, a ratiometric theranostic with strong target affinity and low‐dose efficacy for ovarian metastasis.
Cheng Li +8 more
wiley +1 more source
373P Quality-of-life outcomes in patients with HER2-positive, locally advanced or metastatic breast cancer treated with eribulin mesylate in combination with trastuzumab and pertuzumab in the phase III JBCRG-M06/EMERALD study [PDF]
Norikazu Masuda +19 more
openalex +1 more source